BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9408706)

  • 1. Phase II clinical trial of a vas deferens injectable contraceptive for the male.
    Guha SK; Singh G; Ansari S; Kumar S; Srivastava A; Koul V; Das HC; Malhotra RL; Das SK
    Contraception; 1997 Oct; 56(4):245-50. PubMed ID: 9408706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I clinical trial of an injectable contraceptive for the male.
    Guha SK; Singh G; Anand S; Ansari S; Kumar S; Koul V
    Contraception; 1993 Oct; 48(4):367-75. PubMed ID: 8222664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contraception in male monkeys by intra-vas deferens injection of a pH lowering polymer.
    Guha SK; Ansari S; Anand S; Farooq A; Misro MM; Sharma DN
    Contraception; 1985 Jul; 32(1):109-18. PubMed ID: 4053602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-vas deferens injection of styrene maleic anhydride gel for male contraception: is it safe?
    Singh AK
    J Fam Plann Reprod Health Care; 2002 Oct; 28(4):208-9. PubMed ID: 12419065
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety & efficacy of an intravasal, one-time injectable & non-hormonal male contraceptive (RISUG): A clinical experience.
    Sharma RS; Mathur AK; Singh R; Das HC; Singh GJ; Toor DPS; Guha SK
    Indian J Med Res; 2019 Jul; 150(1):81-86. PubMed ID: 31571633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RISUG (reversible inhibition of sperm under guidance)--an antimicrobial as male vas deferens implant for HIV free semen.
    Guha SK
    Med Hypotheses; 2005; 65(1):61-4. PubMed ID: 15893119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversibility with sodium bicarbonate of styrene maleic anhydride, an intravasal injectable contraceptive, in male rats.
    Koul V; Srivastav A; Guha SK
    Contraception; 1998 Oct; 58(4):227-31. PubMed ID: 9866004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravasal contraception with styrene maleic anhydride and its noninvasive reversal in langur monkeys (Presbytis entellus entellus).
    Lohiya NK; Manivannan B; Mishra PK; Pathak N; Balasubramanian SP
    Contraception; 1998 Aug; 58(2):119-28. PubMed ID: 9773267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical toxicity study of a male injectable antifertility agent (styrene maleic anhydride) in rhesus monkeys, Macaca mulatta.
    Sethi N; Srivastava RK; Nath D; Singh RK
    J Med Primatol; 1991; 20(2):89-93. PubMed ID: 1865485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-invasive reversal of intraluminal vas deferens polymer injection-induced azoospermia--technology.
    Guha SK
    Asian J Androl; 1999 Sep; 1(3):131-4. PubMed ID: 11250780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Charging the vas deferens -- a novel male contraceptive method.
    Koshy LM
    Indian Med Trib; 1994 Aug; 2(14):6. PubMed ID: 12179180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative suitability of DMSO and NaHCO3 for reversal of RISUGĀ® induced long-term contraception.
    Ansari AS; Hussain M; Khan SR; Lohiya NK
    Andrology; 2016 Mar; 4(2):306-13. PubMed ID: 26748683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injectable non-occlusive chemical contraception in the male-I.
    Misro M; Guha SK; Singh H; Mahajan S; Ray AR; Vasudevan P
    Contraception; 1979 Nov; 20(5):467-73. PubMed ID: 43211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety evaluation of a male injectable antifertility agent, styrene maleic anhydride, in rats.
    Sethi N; Srivastava RK; Singh RK
    Contraception; 1989 Feb; 39(2):217-26. PubMed ID: 2706990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated vas occlusion and non-invasive reversal with styrene maleic anhydride for male contraception in langur monkeys.
    Lohiya NK; Manivannan B; Mishra PK
    Int J Androl; 2000 Feb; 23(1):36-42. PubMed ID: 10632760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histology of the rat vas deferens after injection of a non-occlusive chemical contraceptive.
    Verma K; Misro MM; Singh H; Mahajan S; Ray AR; Guha SK
    J Reprod Fertil; 1981 Nov; 63(2):539-42. PubMed ID: 7299756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biophysical mechanism-mediated time-dependent effect on sperm of human and monkey vas implanted polyelectrolyte contraceptive.
    Guha SK
    Asian J Androl; 2007 Mar; 9(2):221-7. PubMed ID: 17334590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of fertility control methods in India.
    Sharma RS; Rajalakshmi M; Sharma RS; Jeyaraj DA
    J Biosci; 2001 Nov; 26(4 Suppl):391-405. PubMed ID: 11779954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Status of spermatogenesis and sperm parameters in langur monkeys following long-term vas occlusion with styrene maleic anhydride.
    Mishra PK; Manivannan B; Pathak N; Sriram S; Bhande SS; Panneerdoss S; Lohiya NK
    J Androl; 2003; 24(4):501-9. PubMed ID: 12826690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histological changes in the vas deferens of rats after injection of a new male antifertility agent "SMA" and its reversibility.
    Sethi N; Srivastava RK; Singh RK
    Contraception; 1990 Mar; 41(3):333-9. PubMed ID: 2323221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.